HHV-6 and HHV-7 antigenemia related to CMV infection after liver transplantation

Journal of Medical Virology

Volumn 78, Issue 6, 2006, Pages 800-805

  Härmä, Maiju ^a   Höckerstedt, Krister ^a   Lyytikäinen, Outi ^b   Lautenschlager, Irmeli ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

CMV; Graft dysfunction; HHV 6; HHV 7; Liver transplantation

Indexed keywords

GANCICLOVIR; MONOCLONAL ANTIBODY; PEROXIDASE; PP65 PROTEIN; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ADULT; AGED; ANTIGEN BLOOD LEVEL; ARTICLE; BLOOD ANALYSIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FEMALE; GRAFT DYSFUNCTION; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; IMMUNOHISTOCHEMISTRY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; VIREMIA; VIRUS CULTURE;

ADULT; AGED; ANTIGENS, VIRAL; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HERPESVIRUS 6, HUMAN; HERPESVIRUS 7, HUMAN; HUMANS; LIVER TRANSPLANTATION; LYMPHOCYTES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; ROSEOLOVIRUS INFECTIONS;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; HERPESVIRIDAE; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7;

EID: 33646485806     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20626     Document Type: Article

References (28)

1. Black JB, Pellet PE. 1999. Human herpesvirus 7. Rev Med Virol 9:245.
2. Boeckh M, Boivin G. 1998. Quantitation of cytomegalovirus: Methodologic aspects and clinical applications. Clin Microbiol Rev 11:533-554.
3. Chang FY, Singh N, Gayowski T, Wagener MM, Marino IR. 1998. Fever in liver transplant recipients: Changing spectrum of etiologic agents. Clin Infect Dis 26:59-65.
4. De Bolle L, Naesens L, De Clercq E. 2005. Update on human herpesvirus 6 biology, clinical features, and therapy. Clin Microbiol Rev 18:217-245.
5. De Clercq E, Naesens L, De Bolle L, Schols D, Zhang Y, Neyts J. 2001. Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8. Rev Med Virol 11:381-395.
6. DesJardin JA, Cho E, Supran S, Gibbon L, Werner BG, Snydman DR. 2001. Association of human herpesvirus 6 reactivation with severe cytomegalovirus- associated disease in orthotopic liver transplant recipients. Clin Infect Dis 33:1358-1362.
7. Dockrell DH, Paya CV. 2001. Human herpesvirus-6 and -7 in transplantation. Rev Med Virol 11:23-36.
8. Dockrell DH, Prada J, Jones MF, Patel R, Badley AD, Harmsen WS, Ilstrup DM, Wiesner RH, Krom RA, Smith TF, Paya CV. 1997. Seroconversion to human herpesvirus 6 following liver transplantation is a marker of cytomegalovirus disease. J Infect Dis 176: 1135-1440.
9. Feldstein AE, Razonable RR, Boyce TG, Freese DK, El-Youssef M, Perrault J, Paya CV, Ishtani MB. 2003. Prevalence and clinical significance of human herpesviruses 6 and 7 active infection in pediatric liver transplant patients. Pediatr Transplant 7:125-129.
10. Griffiths PD, Ait-Khaled M, Bearcroft CP, Clark DA, Quaglia A, Davies SE, Burroughs AK, Rolles K, Kidd IM, Knight SN, Noibi SM, Cope AV, Phillips AN, Emery VC. 1999. Human herpesviruses 6 and 7 as potential pathogens after liver transplant: Prospective comparison with the effect of cytomegalovirus. J Med Virol 59:496-501.
11. Härmä M, Loginov R, Piiparinen H, Halme L, Höckerstedt K, Lautenschlager I. 2005. HHV-6-DNAemia related to CMV-DNAemia after liver transplantation. Transplant Proc 37:1230-1232.
12. Herbein G, Strasswimmer J, Altieri M, Woehl-Jaegle ML, Obert G. 1996. Longitudinal study of human herpesvirus 6 infection in organ transplant recipients. Clin Infect Dis 22:171.
13. Humar A, Malkan G, Moussa G, Greig P, Levy G, Mazzulli T. 2000. Human herpesvirus-6 is associated with cytomegalovirus reactivation in liver transplant recipients. J Infect Dis 181:1450.
14. Kidd JM, Clark DA, Sabin CA, Andrew D, Hassan-Walker AF, Sweny P, Griffiths PD, Emery VC. 2000. Prospective study of human β-herpesviruses after renal transplantation: Association of human herpesvirus 7 and cytomegalovirus co-infection with cytomegalovirus disease and increased rejection. Transplantation 69: 2400-2404.
15. Lautenschlager I, Höckerstedt K, Linnavuori K, Taskinen E. 1998. Human herpesvirus-6 infection after liver transplantation. Clin Infect Dis 26:702-707.
16. Lautenschlager I, Linnavuori K, Taskinen E, Höckerstedt K. 2000. Human herpesvirus-6 antigenemia after liver transplantation. Transplantation 69:2561-2566.
17. Mendez JC, Dockrell DH, Espy MJ, Smith TF, Wilson JA, Harmsen WS, Ilstrup D, Paya CV. 2001. Human β-herpesvirus interactions in solid organ transplant recipients. J Infect Dis 183:179-184.
18. Osman HKE, Peiris JSM, Taylor CE, Warwicker P, Jarret RF, Madeley CR. 1996. Cytomegalovirus disease in renal allograft recipients: Is human herpesvirus-7 a cofactor for disease progression? J Med Virol 48:295-301.
19. Razonable RR, Paya CV. 2002. The impact of human herpesvirus-6 and -7 infection on the outcome of liver transplantation. Liver Transplant 8:651-658.
20. Santoro F, Kennedy PE, Locatelli G, Malnati MS, Berger EA, Lusso P. 1999. CD46 is a cellular receptor for human herpesvirus 6. Cell 99:817-827.
21. Singh N, Carrigan DR, Gayowski T, Marino IR. 1997. Human herpesvirus-6 infection in liver transplant recipients. Documentation of pathogenicity. Transplantation 64:674-678.
22. Tanaka K, Kondo T, Torigoe S, Okada S, Mukai T, Yamanishi K. 1994. Human herpesvirus 7: Another causal agent for roseola (exanthem subitum). J Pediatr 125:1-5.
23. The TH, van der Berg AP, Harmsen MC, van der Bij W, van Son WJ. 1995. The cytomegalovirus antigenemia assay: A plea for standardization. Scand J Infect Dis 99:25-29.
24. Tong CY, Bakran A, Williams H, Cheung CY, Peiris JS. 2000. Association of human herpesvirus 7 with cytomegalovirus disease in renal transplant recipients. Transplantation 70:213-216.
25. Van Der Berg AP, vav der Bij W, van son WJ, Anema J, van der Giessen M, Schirm J, Tegzess AM, The TH. 1989. Cytomegalovirus antigenemia as a useful marker of symptomatic cytomegalovirus disease after renal transplantation: A report of 130 consecutive patients. Transplantation 48:991-995.
26. Ward KN. 2005. The natural history and laboratory diagnosis of human herpesviruses-6 and -7 infections in the immunocompetent. J Clin Virol 32:183-193.
27. Yamanishi K, Okuno T, Shiraki K, Takahashi M, Kondo T, Asano Y, Kurata T. 1988. Identification of human herpesvirus-6 as causal agent for eaxanthem subitum. Lancet 1:1065-1067.
28. Yoshikawa T. 2003. Human herpesvirus-6 and -7 infections in transplantation. Pediatr Transplant 7:11-7.